Fig. 5

Decision curve analysis of clinical model, radiomics model, and combined model in the training cohort (A), internal validation cohort (B), and external validation cohort (C). The combined model had a higher overall net benefit in the differentiation of advanced-stage (dashed line) from early-stage (black solid line) across the full range of threshold probabilities at which an EOC patient would have an FIGO stage-positive